Colorado Center for AIDS Research at the University of Colorado Denver
  • Home
  • Faculty
  • Education
  • Fellowship
  • Research
  • Clinical Programs
  • Tim Gill Endowment
  • Colorado IDSA
  • ACTU
  • CFAR
  • IDGP
  • History
  • Links

UCD Links

  • UCD
  • School of Medicine
  • Department of Medicine
UCD Site Index
A B C D E F G
H I J K L M N
O P Q R S T U
V W X Y Z    
UCD Search

Randall E. Reves MD, MSc

Professor in Department of Medicine and Department of Preventive Medicine and Biometrics

Phone: 303-436-7297
E-mail: rreves@dhha.org
Address: Denver Public Health Department,
605 Bannock Street,
Denver, CO 80204

Postgraduate Training
1975-1976 - University of Wisconsin Hospitals,
Madison, Department of Medicine, Intern
1976-1977 - University of Wisconsin Hospitals,
Madison, Department of Medicine, Junior Resident
1977-1979 - Center for Disease Control,
U.S.P.H.S., Field Services Division,
Jackson, Mississippi, Epidemic Intelligence Service Officer
1979-1980 - University of Texas Medical School at Houston,
Department of Internal Medicine, Senior Resident
1981-1982 - University of Texas Medical School at Houston,
Department of Infectious Diseases and Clinical Microbiology, Fellow

Selected Publications

  1. Burman WJ, Dalton CB, Cohn DL, Butler JR, Reves RR. A cost-effectiveness analysis of directly-observed therapy versus self-administered therapy for treatment of tuberculosis. Chest 112:63-70, 1997.
  2. Burman WJ, Reves RR. A review of false-positive cultures for Mycobacterium tuberculosis and recommendations for avoiding unnecessary treatment. Clin Infect Dis 2000;31:1390-5.
  3. Reichler MR, Reves R, Bur S, Thompson V, Mangura BT, Ford J, Valway SE, Onorato IM. An evaluation of investigations conducted to detect and prevent transmission of tuberculosis. JAMA 2002;287:991-995.
  4. Kong, Po-Marn, Tapy J, Calixto P, Burman WJ, Reves RR, Yang Z, Cave MD. Skin-test screening and tuberculosis transmission among the homeless. Emerg Infect Dis 2002; 8: 1280-4.
  5. Burman WJ. Terra M. Breese P. Cohn D. Reves R. Lack of toxicity from concomitant directly observed disulfiram and isoniazid-containing therapy for active tuberculosis. Intl J Tuberc Lung Dis 2002;6:839-42.
  6. Davidow AL, Mangura BT, Wolman MS, Bur S, Reves R, Thompson V, Ford J, Reichler MR. Workplace contact investigations in the United States. Int J Tuberc Lung Dis. 2003;7:S446-52.
  7. Yun LW, Reves RR, Reichler MR, Bur S, Thompson V, Mangura B, Ford J. Outcomes of contact investigation among homeless persons with infectious tuberculosis. Int J Tuberc Lung Dis. 2003;7:S405-11.
  8. Lobato MN, Reves RR, Jasmer RM, Grabau JC, Bock NN, Shang N; 2RZ Study Group. Adverse events and treatment completion for latent tuberculosis in jail inmates and homeless persons. Chest 2005; 127:1296-303.
  9. Awal K, Sterling TR, Reves R, Vernon A, Horsburgh CR, the Tuberculosis Trials Consortium. Lack of weight gain and relapse risk in a large tuberculosis treatment trial. Am J Respir Crit Care Med. 2006 Aug 1;174(3):344-8.
Centers for AIDS Research

Division of Infectious Diseases
4200 E. 9th Avenue, B168
Denver, CO 80262
Phone 303 315 7233
Fax 303 315 8681